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Abstract:  35 
Molecular chaperones promote the folding and macromolecular assembly of a diverse set of ‘client’ 36 
proteins. How ubiquitous chaperone machineries direct their activities towards specific sets of 37 
substrates is unclear. Through the use of mouse genetics, imaging and quantitative proteomics we 38 
uncover that ZMYND10 is a novel co-chaperone that confers specificity for the FKBP8-HSP90 39 
chaperone complex towards axonemal dynein clients required for cilia motility. Loss of ZMYND10 40 
perturbs the chaperoning of axonemal dynein heavy chains, triggering broader degradation of 41 
dynein motor subunits. We show that pharmacological inhibition of FKBP8 phenocopies dynein 42 
motor instability associated with the loss of ZMYND10 in airway cells and that human disease-43 
causing variants of ZMYND10 disrupt its ability to act as an FKBP8-HSP90 co-chaperone. Our study 44 
indicates that Primary Ciliary Dyskinesia (PCD), caused by mutations in dynein assembly factors 45 
disrupting cytoplasmic pre-assembly of axonemal dynein motors, should be considered a cell-type 46 
specific protein-misfolding disease.  47 
  48 
Introduction: 49 
Macromolecular motors of the dynein family power the essential beating of motile cilia/flagella. 50 
Motile cilia propel sperm cells, generate mucociliary clearance in airways, modulate nodal flow for 51 
embryonic left-right patterning and circulate cerebrospinal fluid inside the brain. Force-generating 52 
dynein motors are large molecular complexes visible by transmission electron microscopy (TEM), as 53 
‘outer’ and ‘inner dynein arms’ (ODA, IDA) spaced at regular intervals along the microtubule 54 
axoneme.  Each ODA motor consists of catalytic heavy chains (HC), intermediate chains (IC) and light 55 
chains (LC); IDAs have a more heterogeneous composition. In mammals, at least 4 ODA and 7 IDA 56 
subtypes exist, each containing different HCs (Kollmar, 2016; Wickstead and Gull, 2007). Defective 57 
dyneins render cilia immotile, resulting in the severe congenital ciliopathy in humans termed 58 
Primary Ciliary Dyskinesia (PCD, OMIM: 242650). Understanding the molecular causes of PCD 59 
requires addressing how complex molecular machines like the dyneins get built during cilium 60 
biogenesis? 61 
PCD causing mutations are most frequently detected in genes encoding structural ODA 62 
subunits such as the intermediate chains (DNAI1 and DNAI2; (Pennarun et al., 1999),(Guichard et al., 63 
2001),(Loges et al., 2008)), or the catalytic heavy chain (DNAH5;(Olbrich et al., 2002)), all of which 64 
disrupt motor assembly and/or function. Consequently, mutant multiciliated cells form cilia but 65 
these fail to move, lacking ODAs by TEM or immunofluorescence. 66 
In addition to these structural subunits of dynein motors, several PCD causing mutations are also 67 
found in a newly discovered set of genes, the "dynein axonemal assembly factors" (DNAAFs) whose 68 
functions are poorly understood. DNAAFs are proposed to assist Heat Shock Protein (HSP) 69 
chaperones to promote subunit folding and cytoplasmic pre-assembly of dynein motors. DNAAFs are 70 
presumed to act as cilial-specific co-chaperones based on proteomic identification of interactions 71 
with both “client” dynein chains and canonical chaperones. Of the known assembly factors, 72 
KTU/DNAAF2 and DYX1C1/DNAAF4 have the most direct biochemical links to HSP90 and HSP70 73 
chaperones, as well as ODA intermediate chain DNAI2 (IC2) (Omran et al., 2008; Tarkar et al., 2013). 74 
Additionally, KTU/DNAAF2, PIH1D3/DNAAF6 and SPAG1 share structural domains with key non-75 
catalytic subunits of the R2TP-HSP90 chaperoning complex, PIH1 and TAH1 respectively. R2TP is a 76 
well established HSP90 co-chaperone which confers specificity during the assembly of multisubunit 77 
enzymes (Pal et al., 2014). DYX1C1/DNAAF4 and LRRC6 each have a CS or p23-like domain(Kott et al., 78 
2012; Tarkar et al., 2013), p23 being a well characterised HSP90 co-chaperone acting during the last 79 
steps of the HSP90 chaperone cycle(J. Li and Buchner, 2013). Interactions between LRRC6, 80 
DNAAF1/LRRC50 and C21ORF59/Kurly/CFAP298 were also recently reported which, coupled with the 81 
phenotypic analysis of Lrrc6 mutant mice, suggests that these assembly factors may function 82 
together in a late-acting complex (Inaba et al., 2016; Jaffe et al., 2016). The functions of DNAAF3 and 83 
DNAAF5/HEATR2 which have no reported links to chaperones, remain elusive (Diggle et al., 2014; 84 
Mitchison et al., 2012). Altogether, the current view is that many DNAAFs transiently participate as 85 
HSP90 co-chaperones during the macromolecular assembly of dynein motors before they are finally 86 
transported into the cilia.  87 
Dynein pre-assembly has been well studied in unicellular eukaryotes such as Chlamydomonas and 88 
Paramecium. For ODAs in Chlamydomonas, affinity purification confirmed all three HCs (HCs; α, β, 89 
and γ, each of ∼500 kDa) and two ICs (IC1, 78 kDa; IC2, 69 kDa) are pre-assembled as a three headed 90 
complex and exist in a cytoplasmic pool prior to ciliary entry (Fok et al., 1994; Fowkes and Mitchell, 91 
1998; Qin et al., 2004). This cytoplasmic pre-assembly pathway is highly conserved and exists in all 92 
ciliated eukaryotes (Kobayashi and Takeda, 2012). While it is clear that the aforementioned 93 
assembly factors aid axonemal dynein pre-assembly, their precise molecular functions within the 94 
pre-assembly pathway still remain largely unknown.  95 
Previous studies had established a strong genetic link between loss of ZMYND10, a putative DNAAF, 96 
and perturbations in dynein pre-assembly (Cho et al., 2018; Kobayashi et al., 2017; Kurkowiak et al., 97 
2016; Moore et al., 2013; Zariwala et al., 2013), however the molecular role of ZMYND10 as a 98 
DNAAF in this process remained unclear.  In order to probe the mammalian dynein pre-assembly 99 
pathway in greater molecular and cellular detail, we generated Zmynd10 null mice by CRISPR 100 
genome editing. We used different motile ciliated lineages at distinct stages of differentiation from 101 
our mammalian mutant model to ascribe a molecular role to ZMYND10 within the dynein pre-102 
assembly pathway.  103 
Our studies implicate a novel chaperone complex comprising of ZMYND10, FKBP8 and HSP90 in the 104 
maturation of dynein HC clients and provide novel evidence of the temporally restricted nature of 105 
interactions within this chaperone-relay system, later involving LRRC6 likely to promote stable inter-106 
subunit interactions. We postulate that a chaperone-relay system comprising of several discrete 107 
chaperone complexes handles the folding and stability of distinct dynein subunits all the while 108 
preventing spurious interactions during cytoplasmic pre-assembly. 109 
  110 
Results: 111 
 112 
Generation of a mammalian PCD model to characterize dynein assembly  113 
We targeted exon 6 of mouse Zmynd10 to target all predicted protein isoforms, with three guide 114 
RNA (gRNA) sequences for CRISPR genome editing and generated several founders with insertion, 115 
deletion and inversion mutations (Figure 1A, Figure 1-figure supplement 1). Null mutations from the 116 
different CRISPR guide RNAs gave identical phenotypes, confirming the phenotypes are due to loss 117 
of ZMYND10, as opposed to off-target effects. For detailed analysis, we focused on a -7bp deletion 118 
mutant line (Zmynd10 c.695_701 p.Met178Ilefs*183), which results in a frame shift with premature 119 
termination. Generation of a null allele was verified by ZMYND10 immunoblotting of testes extracts 120 
(postnatal day 26, P26) and immunofluorescence of multiciliated ependymal cells and lung 121 
cryosections (Figure 1B-D) 122 
 123 
Zmynd10 mutant mice displayed several clinical features of PCD including heterotaxia, progressive 124 
hydrocephaly and chronic mucopurulent plugs in the upper airways, all features consistent with 125 
defects in ciliary motility (Figure 1E-H, Figure 1-figure supplement 2). This was directly confirmed by 126 
high-speed video microscopy of ependymal cells, where cilia of normal number and length were 127 
present but failed to move (Movie 1,2,3,4, Figure 1-figure supplement 3). Ultrastructure analysis of 128 
tracheal cilia axonemes revealed an absence of both outer and inner dynein arms (Figure 1F). The 129 
hydrocephaly phenotype was particularly pronounced on a C57BL6/J background and the majority of 130 
mutants died around weaning (P17-P21). On outbred backgrounds, male infertility and sperm 131 
immotility were also noted in homozygous mutant animals (Figure 1-figure supplement 2, Movie 132 
5,6). These findings demonstrate that ZMYND10 functions are exclusively required in most motile 133 
ciliated cell lineages. 134 
 135 
Mis-assembled dynein motors are blocked from entering cilia and cleared in Zmynd10 mutants  136 
We analysed expression of dynein subunits in different postnatal tissues by immunofluorescence 137 
and immunoblotting from Zmynd10 mutants, focusing on ODA components for which the most 138 
robustly validated immunoreagents exist, to assess whether ZMYND10 loss impacts ODA levels.  In 139 
adult trachea (P26) and oviducts (P26-30), total levels of the ODA HCs DNAH9 and DNAH5, as well as 140 
ICs DNAI1 and DNAI2 were reduced by immunoblot (Figure 2A,B) and immunofluorescence (Figure 141 
2C,D). In agreement with recent studies(Cho et al., 2018), no alteration in dynein transcripts were 142 
detected by RT-qPCRs on mutant oviduct (P12) total RNA, supporting the findings that the zinc-143 
finger MYND domain of ZMYND10 plays cytoplasmic molecular scaffold functions other than a 144 
nuclear transcriptional role (Figure 2E). Critically, immunoblots of P7 Zmynd10 mutant oviduct 145 
lysates, an early stage corresponding to synchronized multicilial axonemal elongation (Dirksen, 146 
1974), showed a laddering of DNAH5 products using an antibody raised against an N-terminal 147 
epitope, indicating post-translational destabilization of DNAH5 in the absence of ZMYND10 (Figure 148 
2F).  149 
 150 
These observations raise the possibility that in the absence of ZMYND10, individual dynein subunits 151 
are initially synthesised during cytoplasmic pre-assembly before a quality-control response is 152 
triggered to clear stalled dynein motor assembly intermediates that fail to reach the mutant 153 
axonemes. The process of mammalian cytoplasmic pre-assembly in terms of dynamics of localization 154 
and levels of dynein subunits has been previously documented(Diggle et al., 2014). ‘Immature’ cells 155 
stain strongly for dynein subunits within the cytoplasm, they appear rounder and their cilia are 156 
apparently shorter than those cells in which dynein subunits exclusively stain the ciliary 157 
compartment. Using Sentan as an independent marker for ‘mature’ motile cilia, we were able to 158 
detect a strong, focused signal at the tips of cilia with exclusively ciliary staining of axonemal dyneins 159 
(Figure 3A, lower left inset). Sentan is a component of the apical ciliary crown structure of mature 160 
motile cilia, where peripheral singlet microtubules are capped by electron dense material abutting 161 
the membrane (Kubo et al., 2008). In contrast, in cells without clear apical Sentan signal, shorter cilia 162 
and cytoplasmic staining (DNAI2, DNALI1) were observed, consistent with these cells being 163 
‘immature’ and in the process of assembling dynein motors and cilia  (Figure 3A, upper right inset). 164 
We therefore postulate that these dynamic patterns of dynein subunits represent ‘mature’ and 165 
‘immature’ cells during assembly of motile cilia, which we can see in cells isolated from nasal 166 
turbinates of control mice (3B middle and upper panels, respectively). In Zmynd10 mutants, no 167 
apparent defects in ciliary length or number were observed (Figure 1-figure supplement 3) however 168 
outer or inner arm dyneins fail to incorporate into mature ciliary axonemes. Importantly, no 169 
cytoplasmic accumulations were noted in ‘mature’ ciliated cells (Figure 3B panels with arrows). 170 
Surprisingly, cytoplasmic staining was observed in both ‘immature’ control and Zmynd10 mutant 171 
cells (Figure 3B, arrowheads). A similar staining pattern was observed for DNALI1 (Figure 3C) 172 
indicating ODA and IDA dynein subunit precursors are initially synthesised normally, further 173 
supporting that ZMYND10 loss does not impact their transcription or translation. Instead, loss of 174 
ZMYND10 leads to dyneins being robustly cleared when their pre-assembly is perturbed.  175 
 176 
ODA and IDA complexes are defective and unstable in the absence of ZMYND10.  177 
As cytoplasmic staining for DNAI2 and DNAH5 was detected in Zmynd10-/- immature respiratory 178 
cells, suggesting that they were initially synthesized, we sought to verify if they were assembled into 179 
complexes using the in situ proximity ligation assay (PLA). In control immature human nasal brush 180 
epithelial cells, we detected PLA signals consistent with DNAI2 and DNAH5 existing in both 181 
cytoplasmic and axonemal complexes (Figure 4A). However, we detected a highly reduced number 182 
of PLA positive foci in nasal epithelial cells of P7 Zmynd10-/- mice, with complexes restricted entirely 183 
to the cytoplasm in contrast to the strong axonemal staining observed in similarly staged controls 184 
(Figure 4B, Figure 4-figure supplement 1). To directly examine the interactions between ODA IC and 185 
HC subunits, we immunoprecipitated endogenous DNAI2 (IC2) from postnatal testes (P26), trachea 186 
(P7 and P90) and oviduct (P7) extracts from Zmynd10-/- animals. DNAI2 co-precipitated DNAI1 (IC1) 187 
at similar levels from both wild type and mutant P26 testes extracts (Figure 4C). This indicated that 188 
loss of ZMYND10 does not primarily impact IC subunit heterodimerization or stability during the 189 
assembly process. Similarly, the relative enrichment of DNAI2 changed very little between mutant 190 
and wild type P7 oviduct and trachea mutant extracts. In contrast, we observed significantly reduced 191 
co-immunoprecipitation of DNAH5 by DNAI2 in P7 oviduct and trachea mutant extracts (0.47 and 192 
0.56 fold reduction respectively, normalized to total levels, Figure 4D,E and Figure 4-figure 193 
supplement 1B,C). Moreover, we observed similar degradative bands (arrowheads) for DNAH5 in 194 
the mutant samples indicating that any DNAH5 that is incorporated may be poorly folded and 195 
unstable, in the absence of ZMYND10. We hypothesize that this reduced association between the 196 
two subunits is due to the HC subunit being in an assembly incompetent, unstable state such that 197 
any substandard complex would be targeted for subsequent degradation (Figure 4F).  198 
 199 
ZMYND10 loss also leads to absent IDA motors from human, fly and mouse cilia(Cho et al., 2018; 200 
Kobayashi et al., 2017; Kurkowiak et al., 2016; Moore et al., 2013; Zariwala et al., 2013). To bypass 201 
the limitation of robust immunoreagents for IDA detection, we used label-free quantitative 202 
proteomics comparing postnatal testes extracts from P25 control and Zmynd10 mutant littermates. 203 
ZMYND10 is highly expressed in the cytoplasm of round and elongating spermatids, as well as 204 
maturing sperm (Figure 5A). In the absence of ZMYND10, mature sperm form but lack expression of 205 
outer and inner dynein subunits (Figure 5B). At P25, we hypothesized that synchronized 206 
spermiogenesis and flagellar extension at this stage would correspond with cytoplasmic pre-207 
assembly of flagellar precursors.  Whilst protein expression profiles were not different between 208 
mutant and controls for differentiation, meiosis and cell death markers (Supplementary File 1), the 209 
expression profile for the motility machinery showed specific and significant changes wherein almost 210 
all the axonemal dynein HCs (outer and inner) detected were reduced whilst the other axonemal 211 
dynein subunits were generally not significantly changed (ICs WDR78 and DNAI1, DNAI2) (Figures 212 
5D, Figure 5-figure supplement 1). This is distinct from previous observations in Chlamydomonas, 213 
where loss of DNAAFs (DNAAF1, 2 and 3) impacting HC stability generally led to an aberrant cytosolic 214 
accumulation of IC subunits(Mitchison et al., 2012), highlighting a key difference between the two 215 
model systems. Components of the radial spokes (RS) and dynein regulatory complex (DRC) were 216 
also unchanged (Figure 5D). Interestingly, several DNAAFs including the co-chaperones DNAAF4 and 217 
DNAAF6 were moderately but significantly up regulated in Zmynd10 mutants suggestive of a 218 
proteostatic response to counter aberrant pre-assembly as it progresses.    219 
 220 
A ZMYND10-FKBP8-HSP90 complex mediates maturation of dynein heavy chains  221 
To further understand how ZMYND10 regulates stability of axonemal dynein HC subunits, we aimed 222 
to generate an endogenous ZMYND10 interactome in P30 mouse testes using two validated 223 
commercial ZMYND10 polyclonal antibodies followed by mass-spectrometry (AP-MS, 224 
Supplementary File 2).  Overlapping interactors in the endogenous affinity purifications of ZMYND10 225 
included ODA HCβ DNAH17 (fold enrichment: 5.8x (P), 2.9x (S); p>0.05), HSP90 (1.5x, 1.8x; p>0.01) 226 
and the well-characterized immunophilin FKBP8 (FK506-binding protein (FKBP) family member) 227 
(6.2x, 8.2x; p>0.001), which can act as an HSP90 co-chaperone (Figure 6A).  228 
 229 
This suggested a novel association between a mammalian DNAAF, putative ‘client’ dynein heavy 230 
chain and the ubiquitous HSP90-FKBP8 chaperone complex during cytoplasmic pre-assembly in vivo. 231 
To validate these interactions, we immunoprecipitated endogenous ZMYND10 and FKBP8 from 232 
control versus mutant testes samples (P30: Figure 6B) and cultures of differentiating human tracheal 233 
epithelial cells (D17 ALI1: Figure 6C), both during cytoplasmic pre-assembly. Indeed, we confirmed 234 
that ZMYND10 interacted with FKBP8 and HSP90, but not with other DNAAFs, including previously 235 
identified interactor LRRC6 (Figure 6B). We also corroborated associations between FKBP8, ODA 236 
HCα DNAH5, HSP90 and ZMYND10 using human Air-Liquid Interface (ALI) cultures and P7 oviducts 237 
(Figure 6C,D), as we failed to find specific immunoreagents against testes ODA HC isoforms (i.e. ODA 238 
HCβ DNAH17 or HCα DNAH8). Taking step-wise ODA macromolecular assembly into account, we 239 
found that whilst DNAI1 co-immunoprecipitated DNAH5, it did not immunoprecipitate either 240 
ZMYND10 or FKBP8 (human ALI tracheal cells D17: Figure 6C). Together our data suggests that the 241 
DNAI1-DNAH5 interaction occurs in a complex that is distinct and downstream from the FKBP8-242 
DNAH5-ZMYND10 complex, as supported by our DM-CHX experiments in which both subunits are 243 
destabilized after 24 hours drug treatment. 244 
 245 
We verified the interactions between ZMYND10 and FKBP8 as well as HSP90 using tagged ZMYND10 246 
affinity purifications from primary ciliated HEK293T cells (Figure 7B). In agreement, direct interaction 247 
between the N-terminus of FKBP8 and MYND domains of ZMYND6/PHD2 (Barth et al., 2009) and 248 
ZMYND20/ANKMY2 (Nakagawa et al., 2007) have also been reported. To characterize the complex 249 
between FKBP8 and ZMYND10 further, we mapped their interaction interface and assessed its 250 
potential biological relevance by generating point mutations in ZMYND10 (Figure 7A). The W423A 251 
mutation falls within the MYND domain and is predicted to functionally disrupt one of two Zn2+-252 
fingers in the MYND domain. Located just before the MYND domain, the T379C PCD patient 253 
mutation (Zariwala et al., 2013) failed to disrupt binding to LRRC6, suggesting some other underlying 254 
pathogenic mechanism exists for this mutation, one which we hypothesize could involve FKBP8. 255 
Affinity purification of ZMYND10-turboGFP variants from HEK293T cells revealed that both point 256 
mutations abolish endogenous FKBP8 binding (Figure 7B). These results indicate that the interaction 257 
interface for FKBP8 extends beyond the MYND domain of ZMYND10, consistent with recent deletion 258 
mutations described in medaka capable of functional rescue (Kobayashi et al., 2017) and suggest 259 
that loss of ZMYND10-FKBP8 interaction may underlie the pathogenic effect of the T379C PCD 260 
mutation. 261 
 262 
FKBP8 is a peptidyl-prolyl isomerase (PPIase), which catalyzes cis-trans isomerization of proline 263 
peptide groups and is one of the rate-determining steps in protein folding. To test whether its PPIase 264 
activity is critical for stabilization of dynein HCs, we treated immature day 17 and mature day 60 265 
(D17 and D60 ALI) human tracheal epithelial cell cultures with a specific PPIase inhibitor DM-CHX 266 
(Edlich et al., 2006) for 24 hours and assayed extracts for stability of ODA subunits by 267 
immunoblotting. Immature cultures were very sensitive to FKBP8 inhibition, where cytoplasmic 268 
levels of DNAH5 were reduced to ~10% of control levels after DM-CHX (150μM). In mature cells, fully 269 
assembled complexes within cilial axonemes were less sensitive to DM-CHX treatment (Figure 7C 270 
and 7D). Surprisingly, a very striking destabilization of DNAI1 was also observed in immature 271 
cultures under these conditions. This supports the possibility that a transient requirement of the 272 
PPIase activity of FKBP8 is necessary for the folding and/or stability of axonemal dyneins in the 273 
cytoplasm.   274 
 275 
Immunofluorescence of mouse tracheal epithelial cells (mTECs) shows that treating parallel cultures 276 
once they have differentiated (D3 ALI, 14 days vehicle followed by 7 days DM-CHX), or as they begin 277 
to differentiate (D3 ALI, 14 days DM-CHX followed by 7 days vehicle) have drastically different 278 
outcomes (Figure 7E). In agreement with immunoblot data, inhibiting the PPIase activity of FKBP8 in 279 
mature ALI cultures does not affect motility or levels of DNAH5 or DNAI2, whilst early inhibition 280 
drastically reduces the levels of these ODA components and abolishes motility (Figure 7E).  281 
 282 
A successive set of complexes are involved in multiple steps of axonemal dynein assembly.  283 
In the chaperone cycle of HSP90, PPIs like FKBP8 are part of the intermediate stage where HSP90 is 284 
bound to the client protein and ATP. Co-chaperones containing a p23-like domain enter at the last 285 
stage of the chaperone cycle when ATP is hydrolysed and client and co-chaperones are released 286 
from HSP90(J. Li and Buchner, 2013). As LRRC6 contains a p23/CS-like domain and was previously 287 
reported to interact with ZMYND10(Moore et al., 2013; Zariwala et al., 2013), we went on to 288 
investigate the effect of LRRC6 on ZMYND10 binding to FKBP8.  289 
 290 
Expression of myc-LRRC6 and ZMYND10-turboGFP followed by affinity purification with a 291 
monoclonal antibody to turboGFP shows that all ZMYND10 variants tested interact with LRRC6, 292 
extending on previous studies (Zariwala et al., 2013). Interestingly, the presence of myc-LRRC6 293 
significantly decreased the association of ZMYND10 to FKBP8 (Figure 8A). These results are 294 
consistent with the canonical roles of p23 co-chaperones and suggest that its presence advances the 295 
HSP90 chaperone cycle releasing all co-chaperones and thus promoting FKBP8 dissociation from 296 
ZMYND10. Whilst we have been unable to confirm endogenous interaction of ZMYND10 and LRRC6 297 
(Figure 6A, 6B, Supplementary File 2), we note that LRRC6 levels are decreased (-7.2 fold change, p= 298 
0.023, Figure 5D, Supplementary File 1) in Zmynd10 mutant testes suggesting some functional 299 
interaction exists during cytoplasmic pre-assembly, highlighting the transient nature of some of 300 
these interactions in vivo. 301 
 302 
Taken together our results suggest that ZMYND10, firstly with FKBP8 and subsequently with LRRC6, 303 
likely participates in an HSP90 chaperone cycle of common clients, the axonemal dynein heavy 304 
chains.  LRRC6 may promote the final maturation and release of clients and co-chaperones onto 305 
subsequent chaperone complexes, including the R2TP and R2TP-like complexes associated with 306 
additional subunits such as the IC1/2 heterodimers, for the next stages of assembly (Figure 8B). 307 
Future studies will determine how HSP90 may be targeted to specific stages of dynein pre-assembly, 308 
but competitive binding through the conserved C-terminal motif MEEVD of HSP90 between discrete 309 
HSP90-co-chaperone-client complexes may confer directionality (Back et al., 2013; Blundell et al., 310 
2017; Lage et al., 2018; Martino et al., 2018; Yamaguchi et al., 2018). Stalling of the folding process 311 
will likely trigger degradation of all folding intermediates regardless of the initial client protein 312 
recruited by the chaperone machinery. 313 
 314 
 315 
 316 
  317 
 318 
Discussion: 319 
Motile cilia are highly complex structures comprising of hundreds of mega-Dalton scale molecular 320 
assemblies. Axonemal dynein motors represent the largest and most complex of such motile ciliary 321 
components. Their coordinated transcription, translation, assembly and transport is critically linked 322 
to ciliary function. The cell appears to have evolved a dedicated chaperone relay system involving 323 
multiple assembly and transport factors to execute distinct steps for their pre-assembly, sometimes 324 
in a tissue- or ciliary domain-specific manner (Dougherty et al., 2016; Fliegauf et al., 2005; 325 
Yamaguchi et al., 2018). 326 
 327 
In the present study we reveal that the DNAAF ZMYND10 co-operates with the ubiquitous co-328 
chaperone FKBP8 and chaperone HSP90 to mediate a key step in the pre-assembly pathway, 329 
specifically maturation of axonemal dynein heavy chains. Using multiple motile ciliated tissues, 330 
including trachea, oviduct and testes, from Zmynd10 null mouse models, we observed reduced 331 
protein abundances for ODA HCs (DNAH5, DNAH9) and ICs (DNAI1 and DNAI2). Proximity ligation 332 
assays and immunopurification of endogenous components suggest that unstable intermediates of 333 
axonemal dynein ODA HCs are primarily affected and unable to fully associate with the IC 334 
heterodimers which are subsequently degraded in Zmynd10 mutants. We provide evidence that the 335 
PPIase activity of FKBP8 is required to stabilize wild type axonemal dynein assemblies. Specific 336 
pharmacological inhibition of FKBP8 PPIase activity phenocopies the motility defects observed in 337 
Zmynd10 mutants. We also confirm that LRRC6 may participate transiently at possibly later stages in 338 
the ZMYND10 dependent HSP90 chaperone cycle. Finally, mutations of ZMYND10 that impair its 339 
ability to interact with the FKBP8-HSP90 chaperone system but not with LRRC6, provide a molecular 340 
explanation for a previously unresolved PCD disease-causing variant (Zariwala et al., 2013).  341 
 342 
HSP90 is emerging as a central feature in the post-translational maturation of axonemal dynein 343 
motors, through at least two distinct regulatory modules. The first one involves the multi-functional 344 
R2TP complex (RUVBL1, RUVBL2, RPAP3, PIH1D1), which is a well-characterized co-chaperone of 345 
HSP90 in the assembly of several multimeric protein complexes (Kakihara and Houry, 2012; Morgen 346 
et al., 2015). Recent reports have highlighted the importance of PIH-domain containing DNAAFs 347 
(DNAAF2 and DNAAF6), RPAP-domain containing SPAG1 as well as Reptin (RUVBL2) and Pontin 348 
(RUVBL1) as regulators of cilia motility (Desai et al., 2018; Dong et al., 2014; Lage et al., 2018; Y. Li et 349 
al., 2017; Olcese et al., 2017; Omran et al., 2008; Paff et al., 2017; Tarkar et al., 2013; Yamaguchi et 350 
al., 2018). All of these factors bear homology to components or form part of the multi-functional 351 
R2TP complex. Functional genetic analysis of the four PIH zebrafish paralogues revealed distinct and 352 
overlapping DNAAF functions in pre-assembly of specific subsets of axonemal dynein motors, in a 353 
tissue-specific as well as axonemal domain-specific manner (Yamaguchi et al., 2018). Biochemical 354 
evidence from endogenous affinity purification of an R2TP adaptor, WDR92 further revealed physical 355 
associations of heavy and intermediate chains of ODA and IDA subunits with R2TP (Lage et al., 2018). 356 
Collectively, these studies link dynein assembly factors to a cilial-specific configuration of the HSP90-357 
R2TP complex. However, further biochemical studies are needed to define how these different cilial-358 
configurations of R2TP-HSP90 and dynein clients interact during the chaperone cycles operative 359 
during axonemal dynein pre-assembly. Our study uncovers a second cilial-specific configuration of 360 
the HSP90 chaperone machinery involving FKBP8 via ZMYND10 in the processing of client axonemal 361 
dynein heavy chains in all motile ciliated tissues studied (Figure 8B). We show that the unchanged 362 
transcript levels do not correlate with the reduced protein levels of axonemal dynein HCs (Figure 2D) 363 
and that unstable heavy chain folding intermediates in Zmynd10 mutant extracts likely result from 364 
degradation of fully translated, improperly folded axonemal dynein HCs. Our results suggest that 365 
ZMYND10 directs and drives an FKBP8-HSP90 cycle, likely involving LRRC6, aiding the maturation of 366 
axonemal dynein HC clients required for their post-translational stability.  367 
 368 
Our multipronged approach using immunofluorescence, proteomic and endogenous interaction 369 
studies all indicate that axonemal dynein HCs are the primary clients of ZMYND10. This is in contrast 370 
to recent studies suggesting that ZMYND10’s primary targets are the ODA ICs, DNAI1 and DNAI2 371 
(Cho et al., 2018; Kurkowiak et al., 2016). Initially, neither the levels of DNAI1 and DNAI2 (Figure 5D, 372 
Supplementary File 2), nor heterodimer formation (Figure 4C) are significantly affected during 373 
cytoplasmic pre-assembly in Zmynd10 mutants. Moreover, our unbiased label-free quantitative 374 
proteomics shows that ZMYND10 loss also specifically impacts IDA HC stability whilst other subunits 375 
or structures remain mostly unaffected. This is distinct from the response seen in PCD models 376 
specifically affecting ODAs wherein complete lack of or misfolding of a single heavy chain in the case 377 
of DNAH5 results in a very specific and limited loss of outer dynein arms only: in DNAH5 patients, 378 
DNALI1 is still found in the ciliary axonemes and IDAs visible by TEM(Loges et al., 2008). The primary 379 
defects we observe support the hypothesis that aberrant HC-IC subunit association and/or the 380 
misfolded HC polypeptides themselves trigger a robust proteostatic response leading to clearance of 381 
non-functional ODA and IDA complexes to mitigate cellular protein stress.  382 
 383 
Our study goes towards addressing a long-standing question of where dynein pre-assembly occurs 384 
within the cytoplasm. Our interaction and mutational studies define a novel ZMYND10-FKBP8-HSP90 385 
complex functioning in dynein pre-assembly, where FKBP8 could tether HC folding to 386 
endomembranes. The participation of FKBP8-HSP90 chaperone complex in protein folding, 387 
activation and clearance has been extensively documented (Banasavadi-Siddegowda et al., 2011; 388 
Barth et al., 2009; 2007; Edlich et al., 2005; Hutt et al., 2012; Saita et al., 2014; Taipale et al., 2014; 389 
Wang et al., 2006). Given the role of this complex in folding and maturation of CFTR on the cytosolic 390 
face of the ER (Hutt et al., 2012; Wang et al., 2006), it raises the possibility that during early stages of 391 
pre-assembly, axonemal dynein heavy chains could also be localized to the cytosolic face of the ER 392 
through ZMYND10’s association with FKBP8. Future work should be directed to further pinpoint 393 
where different assembly steps occur within the cytoplasm. It would be tempting to speculate that 394 
properly folded dynein HCs are subsequently exchanged in the recently described dynamic 395 
cytoplasmic puncta containing rapidly fluxing DNAAFs and less mobile dynein subunits as shown for 396 
DNAI2 and DNALI1, structures termed dynein assembly particles or DynAPs(Huizar et al., 2017; Y. Li 397 
et al., 2017). This ‘phase separated organelle’ model is attractive as increasing local concentration of 398 
specific DNAAF complexes could help overcome the apparently low binding affinities between 399 
different DNAAFs except in these molecular condensates. Indeed, we have been unable to capture 400 
endogenous interactions between LRRC6 and ZMYND10 in vivo (Figure 6A, 6B (Moore et al., 2013; 401 
Zariwala et al., 2013)), suggesting their physiological interactions may be highly transient or 402 
temporally restricted, as opposed to existing in stable complexes. 403 
 404 
Taken together, we propose a revised model of the dynein preassembly pathway (Figure 8B), where 405 
multiple roles for HSP90 are emerging. Here, ZMYND10 acts a novel co-chaperone of the ubiquitous 406 
FKBP8-HSP90 chaperone complex for axonemal dynein HC subunit maturation. Mature, assembly-407 
competent HCs are then handed-off to a subsequent chaperone complex, likely the R2TP complex to 408 
allow for stable associations with other subunits such as the IC1/2 complex, in a ZMYND10-409 
independent step. Working together, this chaperone relay ensures efficient assembly of functional 410 
dynein complexes for subsequent ciliary targeting. Given the critical role ZMYND10 plays in dynein 411 
assembly, we propose a novel alias, DNAAF7 for ZMYND10. Our work on ZMYND10 shows that the 412 
biosynthesis and quality control of dynein motors relies on an elaborate proteostasis network. 413 
Perturbations to this network by pharmacological means or due to genetic defects can disrupt motor 414 
assembly leading to PCD. This represents a paradigm shift in our understanding of PCD pathogenesis. 415 
We propose that the motile ciliopathy Primary Ciliary Dyskinesia (PCD), when caused by defects in 416 
dynein preassembly should be considered a cell-type specific protein misfolding disease, which may 417 
be amenable to therapy by modulation of the cellular proteostasis network. 418 
 419 
 420 
 421 
 422 
 423 
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Abbreviations 437 
 438 
ALI  air-liquid interface 439 
AP-MS  affinity purification mass spectrometry 440 
CRISPR  Clustered Regularly Interspaced Short Palindromic Repeats 441 
D  day post-airlift (ALI) 442 
DNAAF  dynein axonemal assembly factor 443 
DRC  dynein regulatory complex 444 
FKBP  FK506-binding protein 445 
HC  heavy chain 446 
HSP  Heat Shock Protein 447 
IAD  inner arm dynein 448 
IC  intermediate chain 449 
IDA  inner dynein arm 450 
LC  light chain 451 
mTEC  mouse tracheal epithelial cells 452 
MYND  myeloid, Nervy, and DEAF-1 domain 453 
OAD  outer arm dynein 454 
ODA  outer dynein arm 455 
P  postnatal day 456 
PCD  primary ciliary dyskinesia 457 
PPIase  peptidyl-prolyl isomerase 458 
PLA  proximity ligation assay 459 
R2TP  RUVBL1, RUVBL2, TAH1, PIH1 complex 460 
RSP  radial spoke proteins 461 
TEM  transmission electron microscopy 462 
 463 
 464 
 465 
  466 
Figure legends: 467 
 468 
Figure 1. Loss of Zmynd10 in mice results in a PCD phenotype. 469 
(A) Schematic illustrating the null allele generated by a -7bp CRISPR deletion in Zmynd10 exon 6. (B) 470 
Immunoblots from testes extracts from postnatal day 26 (P26) control and mutant male mice show 471 
loss of ZMYND10.  472 
(C, D) Immunostaining for ZMYND10 reveals a complete loss of signal in multiciliated ependymal 473 
cells (C) and lung cryo-sections (D). Multicilia are marked with acetylated α- tubulin (C).  474 
(E) Neonatal Zmynd10 mutants display hydrocephaly; the white arrowhead points to doming of the 475 
head. See also Figure 1- figure supplement 2E. 476 
(F) TEM of tracheal ciliary axoneme cross-sections shows a lack of axonemal ODA (white arrowhead) 477 
and IDA (black arrowhead) dynein arms in mutants.  478 
(G) Representative image of a gross dissection of lungs show situs inversus totalis in mutants. See 479 
also Figure 1- figure supplement F. 480 
(H) H&E staining of coronal sections of nasal turbinates reveals mucopurulent plugs in mutants. 481 
Scale bars in (C)=5μm, in (D)=100μm, in (F)=100nm. 482 
 483 
Figure 1- figure supplement 1. Generation of Zmynd10 mutant mice by CRISPR genome editing. 484 
(A) Schematic of Zmynd10 mouse locus (ENSEMBL: ENSMUSG00000010044) and guide design 485 
targeting critical exon 6 which were cloned into px330 (Addgene:#42230)(Cong et al., 2013).  486 
(B) Validation of activities of gRNAs to generate double-stranded breaks were initially tested in 487 
HEK293 cells by using a reporter to assay reconstitution of EGFP upon cleavage (Addgene: 488 
#50716)(Mashiko et al., 2014).  489 
(C) Table summarizing pronuclear microinjection rounds for generating Zmynd10 mutants. 490 
 491 
Figure 1- figure supplement 2. Detailed phenotypic analysis of  Zmynd10 mutants. 492 
(A) Representative image of a testis from Zmynd10 mutant and wild type control (P150).  493 
(B) As a result of defects in flagellar development, mutants have smaller testes (mean +/- s.e.m, n=3 494 
males/genotype).  Zmynd10 mutants have lower sperm density (mean +/- s.e.m, n=3 495 
males/genotype).  496 
(C) Zmynd10 mutant sperm have reduced motility. Arrows point to static/paralyzed sperm in 497 
mutants. Scale bars= 50μm.  498 
(D) By immunofluorescence, staining of DNAI2 and DNALI1 is absent along Zmynd10-/- flagella 499 
Arrowhead in wild type point to the annulus region and flagellar tip. In the mutant, the arrowhead 500 
points to the annulus.  501 
(E) Coronal vibratome sections of brains show Zmynd10 mutants display dilated lateral ventricles 502 
(arrowhead) due to hydrocephaly.  503 
(F) Zmynd10 mutants display heterotaxy defects. Arrowheads denote direction of the heart’s 504 
position, which is reversed in the mutants; numbers denote lobes of the lungs (1,2 and 3 correspond 505 
to upper, mid and lower lobes of the right lung; 4 and 5 correspond to the upper and lower lobes of 506 
the left lung). 507 
 508 
Figure 1- figure supplement 3. No gross ciliary defects are seen in Zmynd10 mutants. 509 
(A) Transmission electron micrographs (TEM) of tracheal multiciliated cells from wild type and 510 
mutant female mice (P9). Arrows point to cilia on luminal surface of the cells; basal bodies appear 511 
correctly docked in the mutant cells similar to controls. Scale bar = 2μm.  512 
(B) Immunostaining for cilia (acetylated α-tubulin) and apical F-actin (phalloidin) reveals no 513 
cytoskeletal gross defects in Zmynd10 mutants. Scale bars = 10μm  514 
 515 
 516 
Figure 2. Global post-transcriptional destabilization of dyneins occurs in Zmynd10 mutant motile 517 
ciliated tissues. 518 
Immunoblots of whole protein extracts from trachea P26 (A) and P30 oviducts (B) show reduced 519 
abundance of ODA subunits HC-γ, HC-β (DNAH5 and DNAH9), IC1 and IC2 (DNAI1 and DNAI2). 520 
Immunofluorescence of trachea (C) and oviduct (D) tissue sections show loss of axonemal DNAH5 521 
and DNAI2 staining as well as reduced total abundance in Zmynd10 mutants compared to controls. 522 
Brightfield is included in oviduct merge panel (D) to highlight absence of staining in cilia in Zmynd10 523 
mutants. Scale bars in (C) & (D) = 50μm   524 
(E) No significant changes are detected in levels of dynein transcripts by quantitative RT-PCR of 525 
(Dnah5, Dnali1) normalized to (Tbp) in P12 Zmynd10 mutant oviducts (n=3/genotype, dark grey 526 
Zmynd10 mutants).  527 
(F) During early motile ciliogenesis, mildly reduced levels and laddering consistent with degradative, 528 
misfolded intermediates (arrowheads) of ODA HC-γ DNAH5 are detected in Zmynd10 mutant 529 
oviducts (P7). These will be subsequently cleared as tissue differentiation proceeds. 530 
 531 
Figure 3. Loss of ZMYND10 perturbs sub-cellular distribution and levels of dynein complexes 532 
during pre-assembly. 533 
(A) Z-projection through healthy human donor nasal brush immunofluorescence shows a mix of 534 
‘mature’ motile ciliated cells (lower inset, arrow) with exclusively axonemal staining of dynein 535 
subunits (DNAI2 green, DNALI1 magenta) and strong foci of SENTAN (red) at cilial tips, as well as 536 
‘immature’ cells having cytoplasmic staining of dynein subunits and no SENTAN (right inset, 537 
arrowheads). Scale bar =10μm.  538 
(B) Nasal brush immunofluorescence from Zmynd10 mice shows components of outer arm dyneins 539 
(DNAH5, DNAI2) are initially expressed in apical cytoplasm of immature mutant cells (arrowheads) 540 
but subsequently undergo ‘clearance’ in mature cells (lower panels, arrows), whilst all complexes 541 
exclusively translocate into cilia in control mature cells (middle panels, arrows).  542 
(C) Inner arm dynein component DNALI1 is expressed and apically arrested in immature mutant cells 543 
(arrowhead) and unlike controls, will get subsequently get cleared along with the ODA IC, DNAI2, in 544 
mature mutant cells. Scale bars =5μm.  545 
Figure 4. Sequential cytosolic assembly of outer arm dynein components occurs in mammalian 546 
motile ciliogenesis in a process requiring ZMYND10. 547 
(A,B) Z-projections of Proximity Ligation Assay (PLA) on human donor (A) or mouse P7 (B) nasal 548 
brush biopsies confirming ODA subunits (mouse IC2/DNAI2 and HC-γ/DNAH5) are pre-assembled in 549 
the cytoplasm of mammalian multiciliated cells. Control (antibody only control, Ab control) sections 550 
incubated with only DNAH5 show no PLA signal. Red spots denote individual ODA complexes (<40 551 
nm) that appear as peri-nuclear foci in immature cells (arrowhead) and translocate to cilia in mature 552 
cells (arrow). (B) In Zmynd10 mutant cells, reduced number of foci are observed and restricted only 553 
to the cytoplasm, highlighting defects in cytoplasmic pre-assembly. GRP94 was used as a pan-554 
cytosolic marker (A) or phalloidin for apical actin ring (B). Nuclei are stained with DAPI (blue). See 555 
also Figure 4- figure supplement 1A for mouse IC2/DNAI2 and HC-β/DNAH9 PLA. Scale bars in 556 
(A)=5μm and (B)=10μm 557 
(C) Endogenous Immunoprecipitation of DNAI2 from P26 Testes extracts reveals no defects in DNAI2 558 
association with its heterodimeric partner DNAI1 in Zmynd10 mutants.  559 
(D) Endogenous Immunoprecipitation of DNAI2 from P7 oviduct extracts show disruption in 560 
subsequent association between DNAI2 and DNAH5 in mutants compared to controls as quantified 561 
by intensities of the DNAH5 pull-down bands (E). Arrowheads show predicted degradative or 562 
misfolded intermediates of DNAH5 polypeptide in the mutants only. Numbers to the right of panels 563 
denote protein molecular weight in kDa. See also Figure 4- figure supplement 1B,C for analysis in P7 564 
and P90 trachea.  565 
(E) Ratio of mutant versus wild type fold enrichment (from 4D, Figure 4- figure supplement 1B: 566 
IP/input) for DNAI2 and DNAH5, normalized for differences in stability in input, as well as amount of 567 
DNAH5/DNAI2 complexes. 568 
(F) Schematic of axonemal ODA showing the intermediate chain heterodimers (IC) bind normally to 569 
heavy chains (HC) to form the entire motor complex in controls (green) and that this association is 570 
perturbed in mutants (red).  571 
 572 
Figure 4- figure supplement 1. Sequential cytosolic assembly of outer arm dynein components 573 
occurs during mammalian motile ciliogenesis in a process requiring ZMYND10. 574 
(A) Z-projections of Proximity Ligation Assay (PLA) on mouse P7 nasal brush biopsies confirming that 575 
ODA subunits (mouse IC2/DNAI2 and HC-β/DNAH9) are pre-assembled in the cytoplasm. Control 576 
(antibody only control, Ab control) sections were incubated with only DNAH9 antibody and show no 577 
PLA signal. Red spots denote individual ODA complexes (<40 nm) in control cells and cilia. In 578 
Zmynd10 mutant cells, reduced number of foci are observed and restricted only to the cytoplasm, 579 
highlighting defects in cytoplasmic assembly. Phalloidin was used to mark the apical actin ring. 580 
Nuclei are stained with DAPI (blue). Scale bar =10μm. 581 
(B, C) Immunoprecipitation of DNAI2 from P7 trachea extracts show disruption in subsequent 582 
association between DNAI2 and DNAH5 in mutants compared to controls, as quantified by 583 
intensities of the DNAH5 pull-down bands (Figure 4E). In contrast, in P90 adult Zmynd10 mutant 584 
trachea (C), levels of DNAI2 are profoundly affected (input), and negligible complexes can be 585 
purified.  586 
 587 
 588 
Figure 5. Early and specific defects in axonemal dynein heavy chain stability are observed in 589 
Zmynd10 mutants during cytoplasmic assembly. 590 
(A) Immunofluorescence of ZMYND10 in control and mutant adult testes (P150) in asynchronous 591 
seminiferous tubules (arrowhead). (A) ZMYND10 is strongly expressed in primary spermatocytes and 592 
spermatids, where it is restricted to the cytoplasm and never in developing sperm tails. This staining 593 
is lost in mutants. Nuclei are stained with DAPI. Scale bar = 100μm.  594 
(B) Cross-sections of similarly staged seminiferous tubules reveal similar developmental staging of 595 
sperm between adult control and mutants, but loss of DNAI2 (ODA) and DNALI1 (IDA) proteins from 596 
cytoplasm and axonemes (arrowhead) of mutant sperm. Nuclei are stained with DAPI. Scale bars = 597 
50μm, 100μm.  598 
(C) Schematic summarizing mouse spermatogenesis which is initially synchronized postnatally 599 
(stages shown to right), before occurring in asynchronous waves across seminiferous tubules. 600 
Axonemal dynein pre-assembly in the cytoplasm occurs in the spermatid stage around P25 and 601 
continues till flagellogenesis at P30.  602 
(D) Unbiased quantitative proteomics of control and mutant testes (elongated spermatid: P25) 603 
reveal that loss of ZMYND10 leads to a primary reduction in abundance of all dynein HC subunits 604 
during cytoplasmic pre-assembly, whilst other components remain initially unaffected at this stage. 605 
Yellow diamonds highlight significantly (p<0.05) changed hits based on LFQ intensity between 606 
Zmynd10 mutants and wild type littermates (n=3/genotype). Schematic below highlights fold change 607 
of specific subunits on given dynein arms. Some heavy chains had specific multiple isoforms 608 
detected (DNAH7b/c and DNAH12 (E9QPU2*, F6QA95, Q3V0Q1†). See also Supplementary File 1. 609 
Key: IAD: inner arm dynein; OAD: outer arm dynein; DNAAFs: dynein axonemal assembly factors; 610 
RSP: radial spoke protein; DRC: dynein regulatory complex. 611 
Figure 5- figure supplement 1. Peptide intensities across the axonemal dynein heavy chains reveal 612 
profound and significant decreases, whilst other dynein subunits are not affected. 613 
 614 
Intensities of peptides detected by mass spectrometry from P25 testes whole proteome analysis 615 
(Figure 5D) are plotted across the polypeptide lengths for individual axonemal dynein subunits (ODA 616 
and IDA-HCs, ODA-ICs, ODA-LC). TTC25 (ODA-docking complex) and cytoplasmic dynein 1 and 2 617 
heavy chain polypeptides are used as controls. Axonemal dynein heavy chains specifically show 618 
reduced peptide intensities in Zmynd10 mutant testes samples (red) compared to controls (blue). All 619 
the other proteins tested have comparable peptide intensities between mutant and control samples. 620 
 621 
Figure 6. ZMYND10 interacts with a novel chaperone relay at a distinct stage of dynein heavy chain 622 
stability during cytoplasmic assembly. 623 
(A) Summary schematic of affinity purification-mass spectrometry (AP-MS) analysis of endogenous 624 
ZMYND10 interactomes from P30 mouse testes, overlapping between two commercial polyclonal 625 
Sigma (S) and Proteintech (P) antibodies. See also Supplementary File 2.  626 
(B) Endogenous ZMYND10 affinity purification with two validated ZMYND10 antibodies from 627 
Zmynd10 control and mutant P30 testes extracts confirm the ZMYND10 interaction with FKBP8 and 628 
HSP90AB1 (S only) in control samples. These interactions are not found in mutant samples lacking 629 
ZMYND10, serving as specificity controls. An in vivo interaction between ZMYND10 and LRRC6, as 630 
well as with DNAAF1, was not detected in reciprocal endogenous immunoprecipitations in P30 631 
control testes extracts, using rIgG as a control.  632 
(C) Endogenous FKBP8 and DNAI1 immunoprecipitations in differentiating healthy human donor 633 
tracheal epithelial cultures (D17 ALI) both show binding of client DNAH5, the rest of the complexes 634 
are distinct, suggesting they act at sequential steps of assembly.  635 
(D) Endogenous ZMYND10 immunoprecipitation of client DNAH5 and chaperone HSP90, but not 636 
HSP70 from differentiating oviduct epithelial tissue (P7) using rIgG as a control. Protein molecular 637 
weights displayed in KDa. 638 
 639 
Figure 7. Ubiquitous FKBP8 actively participates in axonemal dynein heavy chain stability via its 640 
interaction with ZMYND10. 641 
(A) Summary of mutations generated in ZMYND10-tGFP by site-directed mutagenesis to disrupt the 642 
binding interface for FKBP8, including the W423A mutation predicted to functionally disrupt one of 643 
two Zn2+-fingers in the MYND domain and the T379C PCD patient mutation (Zariwala et al., 2013), 644 
lying just before the MYND domain. 645 
(B) Extracts from transiently transfected HEK293T cells affinity purified against turboGFP shows C-646 
terminal mutations interrupt endogenous FKBP8 and HSP90 binding to ZMYND10. 647 
(C) Healthy human donor tracheal epithelial cultures (MucilAir) before ciliation (D17, post-ALI) or 648 
fully ciliated (D60, post-ALI), were cultured for 24 hours in control (vehicle only) or DM-CHX 649 
(concentrations indicated in μM) before harvesting protein extracts. Immature cultures (D17) were 650 
more sensitive to effects of specific PPIase inhibitor DM-CHX, destabilizing dynein components, 651 
whilst mature cultures were minimally affected.  652 
(D) Quantification of band intensities for DNAH5 (blue) or DNAI1 (yellow) from (C) were normalized 653 
to loading control, and plotted as a fold change after 24 hours. 654 
(E) Z projections of whole-mount immunofluorescence of mouse tracheal epithelial cultures (MTECs) 655 
stained with DNAH5 (magenta), DNAI2 (green) and DAPI (blue) after treatment of three days post-656 
airlift (ALI) with either 100μm DM-CHX or vehicle control for 14 days in culture to differentiate, 657 
followed by switching cultures from control to 100μm DM-CHX (mature: cilial beat visualized) or 658 
from DM-CHX into vehicle control (no cilia beat) and culturing an additional 7 days. Treatment of 659 
mature ciliated cultures had little effect on DNAH5 and DNAI2 levels, whilst treatment during 660 
differentiation disrupted expression of dynein subunits, as evidenced by lack of axonemal staining in 661 
most cells (right panels) but release allows recovery of dynein pre-assembly, mostly cytoplasmic 662 
after 7 days. 663 
 664 
Figure 8. ZMYND10 specifies dynein heavy chains as clients in a chaperone relay during dynein 665 
pre-assembly.  666 
(A) Extracts from transiently transfected RPE-1 cells with ZMYND10-turboGFP variants and human 667 
LRRC6-myc were affinity purified against turboGFP (upper panels). Inclusion of LRRC6 destabilizes 668 
binding of wild-type ZMYND10 to endogenous FKBP8. C-terminal ZMYND10 mutations can interact 669 
with LRRC6. Expression of interactors is confirmed in input cell lysates (lower panels). 670 
(B) During dynein arm assembly in the cytoplasm, ZMYND10 interaction with co-chaperone PPIase 671 
FKBP8 and HSP90 is required for the stabilization and folding of dynein heavy chains (DNAH). 672 
Competitive binding of LRRC6 to ZMYND10 likely advances the HSP90-FKBP8 chaperone cycle taking 673 
the client DNAHs to the next stage of assembly. We propose either R2TP or a specialized R2TP-like 674 
complex may function in parallel to assemble, scaffold or tether the DNAI1-DNAI2 heterodimeric 675 
complex via the PIH-domain proteins, such as DNAAF6, DNAAF2 and PIH1D2. The TPR-domain 676 
containing SPAG1 or DNAAF4 could recruit HSP90 via its MEEVD domain and together with 677 
RUVBL1/RUVBL2 these assembly factors could form a stable platform to promote HC-IC subunit 678 
interactions. This R2TP or R2TP-like complex likely operates distinctly to ZMYND10 as DNAI1/2 679 
heterodimers are detected in Zmynd10 mutants, however these are likely degraded if fully 680 
functional mature complexes (with heavy chains) cannot be assembled. This chaperone-relay system 681 
comprises several discrete chaperone complexes overseeing the folding and stability of discrete 682 
dynein subunits. Folding intermediates are handed off to successive complexes to promote stable 683 
interactions between subunits all the while preventing spurious interactions. Stable dynein 684 
complexes, once formed are targeted to cilia via transport adaptors and intraflagellar transport (IFT). 685 
 686 
Source data: Figures 1-8- Uncropped immunoblots 687 
Images show un-cropped versions of immunoblots. Figure panels used are demarcated with a box 688 
and the detected proteins are labeled. Asterisks are used to denote either non-specific bands (6C, 689 
6D and 7B) or putative degradation products (7E). HE= High exposure, LE=Low exposure 690 
 691 
Movie 1: Rapid ependymal ciliary motility in lateral ventricles of a wild-type mouse 692 
High-speed video microscopy on a coronal brain vibratome section (postnatal day 11 mouse, 693 
littermate control) shows ependymal cilia lining lateral ventricles beating with high frequency in a 694 
wild-type mouse. 695 
 696 
Movie 2: Immotile ependymal cilia lining lateral ventricles of Zmynd10 mutant mouse 697 
High-speed video microscopy on a coronal vibratome section of a brain from a Zmynd10 mutant 698 
mouse (postnatal day 11) shows complete loss of ependymal cilia motility.  699 
 700 
Movie 3: Control murine ependymal cilia with metachronal waveform 701 
High-speed video microscopy on a coronal vibratome section of a Zmynd10 mild hypomorphic 702 
mutant mouse brain (p. M179del; postnatal day 24) shows arrays of cilia beating in a metachronal 703 
waveform and actively generating fluid flow to move particulates over the ventricle tissue. 704 
 705 
Movie 4: Tufts of immotile ependymal cilia in Zmynd10 mutant murine brain 706 
High-speed video microscopy on a coronal vibratome section of a Zmynd10 null mutant mouse brain 707 
(p. L188del; postnatal day 29) shows arrays of immotile cilia lining the ventricle tissue with no active 708 
fluid flow noticeable.  709 
 710 
Movie 5: Aberrant flagellar motility in ZMYND10 mutant murine epididymal spermatozoa 711 
High-speed video microscopy on mature spermatozoa extracted from the epididymis of a 5 month 712 
old Zmynd10 CRISPR founder mutant mouse and slowed-down in methylcellulose. The majority of 713 
spermatozoa were completely immotile but rarely displayed highly aberrant flagellar movements as 714 
observed in the video. 715 
 716 
Movie 6: Sinusoidal flagellar motility in wild type murine epididymal spermatozoa 717 
High-speed video microscopy on mature epididymal spermatozoa extracted from a 5 month-old 718 
wild-type mouse (littermate control) and slowed-down in methylcellulose. Virtually all spermatozoa 719 
underwent forward motion with the flagella displaying a sinusoidal beat pattern. 720 
 721 
Supplementary File 1. Summary of label-free quantitative global proteomics of P25 testes from 722 
Zmynd10+/+ and Zmynd10-/- mice. Label free quantitative (LFQ) proteomics were performed on 723 
whole testes extracts to compare differential protein expression profiles between Zmynd10-/-724 
mutants and age matched (P25) wild-type littermate controls. LFQ intensities from three sets of 725 
biological replicates were averaged per genotype and ratios of enrichment or depletion in mutant 726 
versus wild type were calculated. Significance values were calculated using a Student's paired 2-727 
tailed t-test. For ease of interpretation, the proteins were grouped into their respective complexes 728 
(i.e. Inner Dynein Arm Heavy Chains, Outer Dynein Arm Heavy Chains etc.) 729 
Supplementary File 2. Endogenous ZMYND10 immunoprecipitation protein interactor profiling. 730 
Filtered by significance. Endogenous ZMYND10 was immunoprecipitated from total extracts of 731 
control wild type testes (P30) with two commercial polyclonal antibodies (Proteintech and Sigma). 732 
Proteins that co-precipitated with ZMYND10 in triplicate experiments were identified by tandem 733 
Mass Spectrometry and ranked according to fold-change (FC Ratio) enrichment and significance (t-734 
test p-value) in the ZMYND10 specific pull-downs versus control immunoglobulin pull-downs. 735 
Proteins that commonly precipitated with ZMYND10 using the two separate polyclonal antibodies 736 
were considered putative interactors. A ranked list of these common hits is provided with ZMYND10 737 
and the interactors investigated in this study i.e. FKBP8, HSP90AB1 and DNAH17 highlighted in 738 
green. 739 
Supplementary File 3. Table of antibodies, qRT-PCR primers and plasmids used in this study. 740 
Supplementary File 4. Table of additional mouse primers used in this study. 741 
  742 
Materials and methods: 743 
 744 
Key Resources 
Table     
Reagent type 
(species) or 
resource 
Designation 
Source or 
reference 
Identifiers Additional information 
gene (Mus 
musculus) 
Zmynd10 NA 
MGI:2387863; 
ENSMUSG00000010044;  
Synonym: Blu; Dnaaf7 
strain (M. 
musculus) 
C57BL/6J  JAX 664   
strain (M. 
musculus) 
C3H/HeJ JAX 659   
strain (M. 
musculus) 
CD1 (ICR) Charles River 022  Outbred background 
genetic reagent 
(M. musculus) 
Zmynd10em1Pmi This paper 
Allele symbol: Zmynd10em1Pmi; 
Allele synonym: Zmynd10-; 
Accession ID: MGI:TBC 
CRISPR null allele of 
Zmynd10; Zmynd10 
c.695_701 
p.Met178Ilefs*183 
cell line (H. 
sapiens) 
HEK 293 ATCC CRL-1573 
Human embryonic 
kidney cell line. 
cell line (H. 
sapiens) 
RPE-1 ATCC CRL-4000 
Human retinal 
pigmented epithelial cell 
line immortalized with 
hTERT. 
biological sample 
(M. musculus) 
mouse tracheal 
epithelial cells 
(mTECs) 
This paper NA 
See Vladar and Brody, 
2013 for protocol. 
biological sample 
(H. sapiens) 
MucilAir tracheal 
epithelial cell 
cultures 
Epithelix Sarl EP01MD   
antibody 
Acetylated α-
tubulin 
Sigma  
6-11B-1; T6793, 
RRID:AB_477585 
IF (1:500-2000) 
antibody β-actin Sigma  
AC-15; A1978, 
RRID:AB_476692 
WB (1:1000) 
antibody DNAAF1/LRRC50 Novus Biologicals 
NBP2-01936; RRID: 
AB_2732031 
WB (1:5000) 
antibody DNAH5 PMID: 23525783 Custom made 
IF (1:100), PLA; WB 
(1:5000) 
antibody DNAH5 Sigma  
HPA037470, 
RRID:AB_10672348 
IF (1:100), PLA; WB 
(1:5000) 
antibody DNAH9 PMID: 24421334 Custom made 
IF (1:100), PLA; WB 
(1:5000) 
antibody DNAH5 Sigma  
HPA037470, 
RRID:AB_10672348 
WB (1:5000) 
antibody DNAI1 Abcam  ab171964; RRID: AB_2732030 WB (1:5000) 
antibody DNAI2 Abnova  
M01 clone IC8; H00064446-
M01, RRID:AB_426059 
IF (1:100), PLA; WB 
(1:5000) 
antibody DNAI2 Proteintech  
17533-1-AP; 17533-1-AP, 
RRID:AB_2096670 
IF (1:100); WB (1:5000); 
IP (1.5μg-3μg/IP) 
antibody DNALI1 Santa Cruz 
N-13; sc-160296, 
RRID:AB_2246230 
IF (1:75); WB (1:1000) 
antibody FKBP8 Proteintech  
11173-1-AP, 
RRID:AB_10597097 
WB (1:5000); IP (1.5μg-
3μg/IP) 
antibody FKBP8 R&D Systems  MAB3580, RRID:AB_2262675 WB (1:5000) 
antibody γ tubulin Abcam  
GTU-88; ab11316, 
RRID:AB_297920 
IF (1:500) 
antibody GAPDH Abcam  ab8245, RRID:AB_2107448 WB (1:5000) 
antibody tGFP  Origene  TA150041, RRID:AB_2622256 IF (1:200); WB (1:5000) 
antibody GFP Santa Cruz  FL; sc-8334, RRID:AB_641123 
WB (1:5000); IP (1.5μg-
3μg/IP) 
antibody GRP-94/HSP90B1 Thermo Scientific  
clone 9G10; MA3-016, 
RRID:AB_2248666 
IF (1:100); WB (1:5000) 
antibody HSP70 Santa Cruz  
K-20; sc-1060, 
RRID:AB_631685 
WB (1:5000) 
antibody HSP90AB1 R&D Systems  
MAB32861, 
RRID:AB_2121071 
WB (1:5000) 
antibody HSP90 Santa Cruz  
Clone F-8; sc-13119, 
RRID:AB_675659 
WB (1:5000) 
antibody 
LRRC6 (Hiroshi 
Hamada) 
PMID:27353389 Custom made 
WB (1:5000), a gift from 
Hiroshi Hamada 
antibody SENTAN  Sigma 
HPA043322 , RRID: 
AB_10793945 
IF (1:150) 
antibody ZMYND10  Proteintech  
14431-1-AP, 
RRID:AB_2218002 
WB (1:5000); IF (1:100); 
IP (1.5μg-3μg/IP) 
antibody ZMYND10  Sigma  
HPA035255, 
RRID:AB_10601928 
WB (1:5000); IF (1:100); 
IP (1.5μg-3μg/IP) 
recombinant DNA 
reagent 
pCMV6-Zmynd10-
tGFP  
Origene MG207003 
Mouse Zmynd10 ORF 
with C-terminal turbo-
GFP tag under CMV 
promoter in plasmid 
with ampicillin 
resistance gene  
recombinant DNA 
reagent 
pCMV6-DNAAF5-
tGFP  
Origene MR221395 
Mouse Dnaaf5 ORF with 
C-terminal turbo-GFP 
tag under CMV 
promoter in plasmid 
with ampicillin 
resistance gene  
recombinant DNA 
reagent 
pRK5-Myc-LRRC6  PMID:23891469 NA 
Human LRRC6 ORF with 
myc tag; gift from the 
Hildebrandt and Gee 
labs  
recombinant DNA 
reagent 
pX330-U6-
Chimeric_BB-CBh-
hSpCas9 
PMID: 23287718  Addgene:#42230 
A human codon-
optimized SpCas9 and 
chimeric guide RNA 
expression plasmid. 
pX330-U6-Chimeric_BB-
CBh-hSpCas9 was a gift 
from Feng Zhang. 
recombinant DNA 
reagent 
pCAG-EGxxFP PMID: 24284873   Addgene:#50716 
 5’ and 3’ EGFP 
fragments that shares 
482bp were placed 
under ubiquitous CAG 
promoter. Used for 
validation of gRNA 
sequences by DSB 
mediated EGFP 
reconstitution. pCAG-
EGxxFP was a gift from 
Masahito Ikawa 
sequence-based 
reagent 
mouse Dnahc5 
qRT-PCR primers 
This paper   
AAGCTGTTGCACCAGACC
AT/ 
CCCAGGTGGCAGTTCTGT
AG; Probe:88  
sequence-based 
reagent 
mouse Dnali1 qRT-
PCR primers 
This paper   
AGTTCCTGAAACGGACC
AAC/ 
TGAGACCCATGTGGAAA
TGA;  Probe:97  
sequence-based 
reagent 
mouse Zmynd10 
qRT-PCR primers 
This paper   
GCCATCCTTGATGCAACT
ATC/ 
CAATCAGCTCCTCCACCA
G;  Probe:64 
sequence-based 
reagent 
mouse Tbp qRT-
PCR primers 
This paper   
GGGGAGCTGTGATGTGA
AGT/ 
CCAGGAAATAATTCTGGC
TCA;  Probe:97 
chemical 
compound, drug 
N-(N’N’-
Dimethylcarboxami
domethyl)cyclohexi
mide (DM-CHX) 
PMID:16547004   
FKBP8 inhibitor, 1mM 
stock in sterile PBS 
software, 
algorithm 
Fiji 
    PMID: 
22743772  
    
software, 
algorithm 
Nis-Elements AR 
V4.6 
Nikon 
Instruments 
    
software, 
algorithm 
Imaris V9.1 Bitplane   
software, 
algorithm 
MaxQuant 
    PMID: 
19029910 
    
software, 
algorithm 
Andromeda PMID: 21254760     
software, 
algorithm 
Perseus 
    PMID: 
27348712 
  
software, 
algorithm 
Crapome 
    PMID: 
23921808 
  
 745 
 746 
 747 
 748 
Generation of CRISPR mouse mutants  749 
CAS9-mediated gene editing was used to generate mutant mice for Zmynd10 750 
(ENSEMBL:ENSMUSG00000010044) using three (guide) gRNAs each targeting “critical” exon 6. Guide 751 
RNA sequences were cloned into a pX330 vector (Addgene:#42230)(Cong et al., 2013) and efficacy 752 
was first validated using a split GFP assay in HEK293 cells (Addgene: #50716)(Mashiko et al., 2014). 753 
Pronuclear injections of 5ng/μl of purified plasmid DNA of pX330 constructs were injected into 754 
fertilized C57BL/6J eggs, which were cultured overnight until the two-cell stage before transferring 755 
to pseudopregnant females. PCR based screening, Sanger sequencing and characterization of genetic 756 
mutations of founder animals (F0) was performed. A genotyping was developed using a restriction 757 
digest of a PCR product for the -7bp deletion line used in this study. Animals were maintained in SPF 758 
environment and studies carried out under the guidance issued by the Medical Research Council in 759 
‘‘Responsibility in the Use of Animals in Medical Research’’ (July 1993) and licensed by the Home 760 
Office under the Animals (Scientific Procedures) Act 1986. 761 
 762 
Cytology, Histology and TEM  763 
Motile multiciliated ependymal cells were obtained from mouse brains (>P7) using a published 764 
protocol(Grondona et al., 2013). Mouse respiratory epithelial cells were obtained by exposing the 765 
nasal septum and scraping cells off the epithelium with an interdental brush (TePe, 0.8mm 766 
ExtraSoft) followed by resuspension in DMEM (isolated from animals at P7-P29). Cells were spread 767 
on superfrost slides, air-dried and processed for immunofluorescence. This was modified for 768 
proximity ligation assay (PLA) where cells were resuspended in PBS, then fixed 4%PFA/3.7% 769 
sucrose/PBS for 30 minutes on ice and cytospun onto Superfrost slides. Human respiratory epithelial 770 
cells by brush biopsying the nasal epithelium of healthy human donors or P7 neonatal mice were 771 
processed for proximity ligation assay using a Duolink PLA starter kit (DUO92101, Sigma-Aldrich), as 772 
per the manufacturer’s instructions following PFA fixation and 0.25%Triton-X100/TBS 773 
permeabilization 10 minutes. Alexa-488 phalloidin (Thermo Fischer) or rat anti-GRP94 (Thermo 774 
Fischer) counterstaining was done post-PLA protocol, prior to mounting in Duolink® In Situ Mounting 775 
Medium with DAPI (Sigma Aldrich). Trachea (P7), testes (P150) and oviducts (P7) were dissected and 776 
immersion fixed in 4% paraformaldehyde (from 16% solution, Thermo Fischer) overnight and 777 
cryosectioned for immunofluorescence staining with antibodies to ZMYND10, acetylated α-tubulin 778 
or dynein components (Diggle et al., 2014). Nasal turbinates were similarly fixed and processed for 779 
paraffin sectioning stained with H&E to reveal mucus plugs. Immunofluorescence images were 780 
acquired at either 60x or 100x optical magnification as confocal stacks through whole cells and tissue 781 
sections using a Nikon A1R confocal microscope and displayed as Z-projections. Epidydymal 782 
spermatozoa were isolated by dissecting the cauda and caput regions of the epididymides in M2 783 
media (Life Technologies), spread onto superfrost slides and air-dried followed by fixation and 784 
permeabilisation for immunofluorescence, as previously described(Diggle et al., 2014). For counting, 785 
sperm from the cauda epididymides were immobilized by diluting in H2O and counts were 786 
performed using a haemocytometer. For transmission electron microscopy, trachea tissue samples 787 
were dissected into PBS and immersion fixed in 2% PFA/2.5% glutaraldehyde (Sigma-Aldrich)/0.2M 788 
Sodium Cacodylate Buffer pH7.4 with 0.04% CaCl2(Hall et al., 2013). Samples were cut into semi-thin 789 
and ultrathin sections and imaged by transmission electron microscopy (EM Services, Newcastle 790 
University Medical School). 791 
 792 
Live brain sectioning and high-speed videomicroscopy of ependymal cilia 793 
Whole brains were isolated from neonatal mice in ice cold PBS and kept on ice. Brains were 794 
mounted vertically along the caudo-rostral axis on a petri dish and embedded in low melting point 795 
agarose (Thermo Scientific). 400μm thick vibratome sections of live brain tissue were obtained and 796 
floated onto wells of a glass bottom multiwell plate (Greiner Sensoplates cat.662892) containing 797 
DMEM and maintained at 37°C and 5% CO2. Sections were imaged on a Nikon macroscope to 798 
visualize dilated lateral ventricles. Motile cilia beating along the surfaces of the lateral walls were 799 
visualized and motility was recorded using a high-speed videomicroscopy Andor CCD camera 800 
attached to a confocal capture set-up. 801 
 802 
Immunoprecipitations (IP) and immunoblots  803 
Endogenous immunoprecipitations were performed using protein extracts either from multiciliated 804 
cell cultures or motile ciliated tissues lysed under mild lysis conditions (50 mM Tris-HCl (pH 7.5), 100 805 
mM NaCl, 10% Glycerol, 0.5 mM EDTA, 0.5% IGEPAL, 0.15% Triton-X 100 and Halt Protease Inhibitor 806 
Single use cocktail EDTA free (Thermo Fischer)). For detecting HSP90 interactions, we included 807 
sodium molybdate (Sigma-Aldrich) in the IP buffer aiming to reduce ATP hydrolysis and client 808 
release(Sullivan et al., 2002). To detect interactions between ODA subunits, a DNAI2 antibody 809 
(Abnova H00064446-M01, RRID:AB_426059) was used as a bait to enrich DNAI2 containing 810 
complexes from mouse trachea and oviduct lysates. Immunoblotting was performed using DNAI1 811 
(Abcam ab171964, RRID:AB_2732030) and DNAH5 (N-terminal epitope, M. Takeda). For ZMYND10 812 
interaction studies, extracts from whole testes (P30) and differentiating mouse P7 oviducts were 813 
used. Endogenous ZMYND10 containing complexes were pulled out using two validated ZMYND10 814 
polyclonal antibodies (Sigma HPA035255, RRID:AB_10601928; Proteintech 14431-1-AP, 815 
RRID:AB_2218002). Immunoblotting was performed using an HSP90 antibody (Santa Cruz sc-13119, 816 
RRID:AB_675659). For human samples, endogenous FKBP8, DNAI1 and DNAI2 pulldowns were 817 
perfomed on lysates from normal human airway epithelial cells (MucilAir, Epithelix Sarl) grown at 818 
air-liquid interface for 17days (immature cells). Antibodies for FKBP8 (Proteintech 11173-1-AP, 819 
RRID:AB_10597097), DNAI1 (Abcam ab171964; RRID:AB_2732030) and DNAI2 (Abnova H00064446-820 
M01, RRID:AB_426059) were used as baits and antibodies for DNAH5 (Sigma HPA037470, 821 
RRID:AB_10672348) and ZMYND10 (Proteintech 14431-1-AP, RRID:AB_2218002) were used to 822 
detect these interactors. An isotype-matched IgG rabbit polyclonal antibody (GFP: sc-8334, 823 
RRID:AB_641123, Santa Cruz) was used as control. In all pull-down experiments, immunocomplexes 824 
were concentrated onto Protein G magnetic beads (PureProteome, Millipore). Following washes, 825 
immunocomplexes were eluted off the beads and resolved by SDS-PAGE for immunoblotting. 826 
Alternatively, beads were processed for on-bead tryptic digestion and mass-spectrometric analysis. 827 
For overexpression pull-downs, of mouse Dnaaf5-tGFP (Origene- MG221395), Zmynd10-tGFP 828 
(Origene, MG207003) and myc-Lrrc6 (Zariwala et al., 2013) were transiently transfected 829 
(Lipofectamine2000) into hTERT-RPE (ATCC CRL-4000) and HEK 293 (ATCC CRL-1573), which were 830 
tested regularly for mycoplasma. Site-directed mutagenesis was performed using two 831 
complementary PCR primers containing the desired nucleotide changes (PrimerX tool) to amplify 832 
Zmynd10-tGFP with proof reading DNA polymerase (Agilent II), followed by DpnI digestion, E coli 833 
transformation and sequencing of the thus recovered plasmids. Subsequent affinity purification 834 
using a turboGFP antibody (Evrogen TA150041, RRID:AB_2622256) was used to isolate fusion 835 
proteins 24 hours post-transfection followed by immobilization onto protein G beads. For 836 
immunoblots, proteins were resolved by SDS-PAGE using 3-8% Tris-Acetate gels or 4-12% Bis-Tris 837 
precast gels (NuPage Life Technologies), then transferred using XCell II Blot module (Life 838 
Technologies) to either nitrocellulose or PVDF membranes followed by manual or iBind Western 839 
(Thermo Fisher) system for antibody binding. Protein bands were detected using SuperSignal West 840 
Femto or Pico kit (Thermo Scientific). Supplementary File 3 contains a list of reagents used.  841 
  842 
Mass Spectrometry and proteomic data analysis 843 
For whole tissue proteome analysis, the Filter Aided Sample Preparation (FASP) method was 844 
used(Wiśniewski et al., 2009). Briefly, mouse testes samples were homogenized in a lysis buffer 845 
consisting of 100mM Tris (hydroxymethyl)amino-methane hydrochloride (Tris-HCl), pH 7.5, in 846 
presence of protease (Complete Mini Protease Inhibitor Tablets, Roche and 1mM 847 
Phenylmethylsulfonyl fluoride, , Sigma) and phosphatase inhibitors (PhosSTOP Phosphatase Inhibitor 848 
Cocktail Tablets, Roche). Samples were further processed and peptides and proteins were identified 849 
and quantified with the MaxQuant software package, and label-free quantification was performed 850 
by MaxLFQ, as described in (Hall et al., 2017). The false discovery rate, determined by searching a 851 
reverse database, was set at 0.01 for both peptides and proteins. All bioinformatic analyses were 852 
performed with the Perseus software. Intensity values were log-normalized, 0-values were imputed 853 
by a normal distribution 1.8 π down of the mean and with a width of 0.2 π. Statistically significant 854 
variance between the sample groups was tested by a permutation-based FDR approach and a 855 
Student’s t test with a p value cut-off of 0.01. Total proteomic data are available via 856 
ProteomeXchange with identifier PXD006849 and are summarised in Supplementary File 1 857 
 858 
To examine endogenous ZMYND10 interactions from postnatal day 30 (P30: a period of 859 
synchronized flagellogenesis) testes extracts using two well-validated polyclonal antibodies 860 
(ZMYND10 Proteintech and Sigma) using an IP/MS workflow carried according to (Turriziani et al., 861 
2014). Mass spectra were analysed using MaxQuant software and label-free quantification intensity 862 
values were obtained for analysis. T-test p-values between MS runs were calculated. MS datasets 863 
were ranked by log2 fold-change (enrichment) over IgG controls (Supplementary File 2). As a filtering 864 
strategy to find 'true' interactions, we used the CRAPome repository (http://www.crapome.org/.) 865 
containing a comprehensive list of the most abundant contaminants commonly found in AP/MS 866 
experiments(Mellacheruvu et al., 2013). To aid filtering, we used an arbitrary threshold of 25 (i.e. 867 
proteins appearing in >25 out of 411 experiments captured in the CRAPome repository) were 868 
removed from further analysis. Filtered interactors common to both ranked datasets were 869 
prioritized for further studies for validation as interactors of ZMYND10 in vivo. The mass 870 
spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the 871 
PRIDE partner repository with the dataset identifier PXD006849 and summarised in Supplementary 872 
File 2.  873 
 874 
Mouse tracheal epithelial cultures 875 
Mouse tracheal epithelia cells (mTECs) were isolated from the tracheas of 5-7 week old outbred 876 
mice, and then studied as passage 0 cells(Vladar and Brody, 2013). Cells were cultured on 877 
semipermeable supported membranes (Transwell; Costar, Corning, NY), as previously 878 
described(Vladar and Brody, 2013). Y276342 (StemCell, UK) at 10 mM was added to the medium 879 
during the proliferation stages to promote basal cell proliferation. For FKBP8 inhibition studies, DM-880 
CHX (1mM stock, in PBS) was diluted to 100μm working concentration in NuSerum media and added 881 
to wells every 2 days from 3 days ALI (immature treatment) or after 14 days (mature treatment). For 882 
detection of DNAH5 (Takeda custom) and DNAI2 (Abnova H00064446-M01, RRID:AB_426059) from 883 
mTECs, membrane from inserts were removed and stained with antibodies as described above. 884 
 885 
Reverse transcription Quantitative Real time‐PCR (RT qPCR)  886 
Total RNA was isolated from freshly dissected tissue or tissue stored in RNAlater (Qiagen). Isolation 887 
was carried out using RNeasy Mini Kit or RNeasy Fibrous Tissue Mini Kit (Qiagen) following 888 
manufacturer’s protocol. RNA samples were treated with Turbo DNAse to remove genomic DNA 889 
contamination using the Turbo DNA free kit (Ambion). Intron-spanning RT-qPCR assays were 890 
designed using the Universal Probe Library probe finder tool (Roche) to identify transcript specific 891 
primer-probe sets listed in supplementary table. Three separate experimental runs were carried out 892 
for each plate. All runs were done on three individual biological replicates. Data was analysed using 893 
Roche LC480 software. Subsequently, a paired two-tailed students t-test was used to compare 894 
differences in the mean expression values between wild type and mutant samples.  895 
 896 
DM-CHX FKBP8 inhibitor studies 897 
Lyophilized FKBP8 inhibitor N-(N’N’-Dimethylcarboxamidomethyl)cycloheximide (DM-CHX) (Edlich et 898 
al., 2006) was dissolved in sterile PBS in a 1mM stock and diluted further to working concentrations 899 
in MucilAir™ media (EPITHELIX Sàrl). MucilAir tracheal epithelial cultures (EPITHELIX Sàrl) inserts 900 
from healthy human donors (same for each stage, immature D17 after air-lift or mature D60 after 901 
air-lift) were incubated with DM-CHX for 24 hours and harvested in mild lysis buffer, (50 mM Tris-HCl 902 
(pH 7.5), 100 mM NaCl, 10% Glycerol, 0.5 mM EDTA, 0.5% IGEPAL, 0.15% Triton-X 100 and Halt 903 
Protease Inhibitor Single use cocktail EDTA free (Thermo Fischer).  904 
 905 
Imaging 906 
Fluorescent confocal images (PLA, IF, ICC) were acquired using a 60x Apochromat λS or 100x Plan 907 
Apochromat VC 1.4 DIC N2 lens was performed using a Nikon A1R confocal microscope. Data were 908 
acquired using NIS Elements AR software (Nikon Instruments Europe, Netherlands). mTEC 909 
wholemount images were acquired using 20x Plan Apochromat VC 0.75 DIC N2 or air 40x Plan Fluar 910 
0.75 DIC N2 lens on the multimodal Imaging Platform Dragonfly (Andor Technologies, Belfast UK). 911 
Data were collected in Spinning Disk 25µm pinhole mode on the high sensitivity iXon888 EMCCD 912 
camera. Z stacks were collected using a Mad City Labs Piezo. Data was visualized using IMARIS 8.4 913 
(Bitplane). 914 
  915 
Statistics 916 
Statistical tests were performed using GraphPad Prism 7, (GraphPad Software, California) as 917 
described in the text. 918 
 919 
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